Top Story

Sugarpod wins diabetes challenge

October 22, 2017

Sugarpod by Wellpepper, a comprehensive diabetes care plan that sends personalized messages to users, has won the Alexa Diabetes Challenge, according to a press release from Merck & Co.

The Alexa Diabetes Challenge, sponsored by Merck and Amazon Web Services, was a competition of innovative, voice-enabled technologies for those with recently diagnosed type 2 diabetes.

Genome data provides support for link to thyroid cancer

October 21, 2017
Recent findings from a large international genetic database provided new insight on genetic mutations known to cause thyroid cancer, according to a press release from…
Meeting News

Experts list year’s top findings in menopause, women’s health

October 20, 2017
PHILADELPHIA — At the Annual Meeting of the North American Menopause Society, leaders in the field presented recent standout articles in the field of menopause and…
In the Journals PlusPerspective

SCALE: Liraglutide increases health-related quality of life in obesity, prediabetes

October 20, 2017
Adults with obesity and prediabetes showed 3-year improvements in health-related quality of life and weight loss with once-daily subcutaneous liraglutide compared with…
In the Journals Plus

Long-acting pasireotide safe, effective for recurrent Cushing’s disease

October 20, 2017
In patients with persistent or recurring Cushing’s disease after surgery, monthly pasireotide was safe and effective, leading to normal urinary free cortisol…
More Headlines »

The Future of the Lipid Panel: An NLA Expert Discussion

This educational activity is supported by an educational grant from Quest Diagnostics, Inc.

Past-President of the National Lipid Association and Editor-in-Chief of the Journal of Clinical Lipidology, Dr. W…
More »
Meeting News

VIDEO: Anabolic agents should be prescribed early for high-risk osteoporosis

October 17, 2017
More »
Resource Centers


Rapid Response from Austin: Expanding Options in Type 2 Diabetes Management

This activity is supported by educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.

Approximately 150 million people worldwide have diabetes mellitus and this number is expected to double by 2025…
More »
Current Issues
View the Current Issue